Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 8;63(2):2302188.
doi: 10.1183/13993003.02188-2023. Print 2024 Feb.

Fibroblast heterogeneity in pulmonary fibrosis: a new target for therapeutics development?

Konstantin Tsoyi  1 , Ivan O Rosas  2
Affiliations
Free article
Editorial

Fibroblast heterogeneity in pulmonary fibrosis: a new target for therapeutics development?

Konstantin Tsoyi et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: I.O. Rosas has received funding from Boehringer Ingelheim, Genentech/Roche and Tavardi Therapeutics, and has participated in advisory boards for Boehringer Ingelheim, Avalyn Pharma and Structure Therapeutics. K. Tsoyi has no potential conflicts of interest to disclose.

Comment on

  • Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts.
    Mayr CH, Sengupta A, Asgharpour S, Ansari M, Pestoni JC, Ogar P, Angelidis I, Liontos A, Rodriguez-Castillo JA, Lang NJ, Strunz M, Porras-Gonzalez D, Gerckens M, De Sadeleer LJ, Oehrle B, Viteri-Alvarez V, Fernandez IE, Tallquist M, Irmler M, Beckers J, Eickelberg O, Stoleriu GM, Behr J, Kneidinger N, Wuyts WA, Wasnick RM, Yildirim AÖ, Ahlbrecht K, Morty RE, Samakovlis C, Theis FJ, Burgstaller G, Schiller HB. Mayr CH, et al. Eur Respir J. 2024 Feb 8;63(2):2301326. doi: 10.1183/13993003.01326-2023. Print 2024 Feb. Eur Respir J. 2024. PMID: 38212077 Free PMC article.

LinkOut - more resources